Single oral dose pharmacokinetics and comparative bioavailability of danazol in humans

W. D. Hooper, M. J. Eadie, R. G. Dickinson
Biopharmaceutics & drug disposition · 1991 · vol. 12(8) , pp. 577–582 · doi:10.1002/bdd.2510120804 · PMID:1801964 · W1974059814
RCT OA: closed CC0 ⤵ 6 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study evaluated the pharmacokinetics and bioavailability of two danazol capsule formulations in healthy males, finding no statistically significant differences between them.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A comparative bioavailability study was conducted with two capsule formulations of danazol (200 mg) in 16 healthy adult male volunteers. Fasting subjects received single doses (400 mg) of each formulation on separate occasions 1 week apart. Blood samples were drawn at specified times up to 32 h after the dose and danazol concentrations in plasma were determined by a specific and sensitive HPLC method. The results for one subject were excluded as outlier values. The data from the other 15 subjects showed small differences, which did not achieve statistical significance between the formulations with respect to Cmax, Tpeak and AUC0-infinity. The mean elimination half-life for danazol was 9.44 +/- SD 2.74 h and the mean apparent total body clearance was 710 +/- SD 2161 h-1. These data differed from previously published results, probably as a result of the more sensitive and specific assay method used in the present work. It is likely that a high proportion of the oral dose of danazol is eliminated by presystemic metabolism.

My notes (saved in your browser only)

MeSH descriptors

Danazol Administration, Oral Adolescent Adult Biological Availability Chemistry, Pharmaceutical Danazol Danazol Humans Male

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (8)

Cited by (6)

Source provenance

openalex
last seen: 2026-05-11T06:25:09.493344+00:00
pubmed
last seen: 2026-10-08T21:04:47.165929+00:00
unpaywall
last seen: 2026-10-14T06:23:58.021457+00:00
License: CC0 · commercial use OK